Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 3/20 | 0.44 |
| ▸ | AGXT | P21549 | 2/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 2/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15516632 | 0.86 | LOXL2 (0.40) | TAAR1IDO1MAOAMAOBALDH1A1 | |
| SCHEMBL27969132 | 0.81 | TAAR1 (0.52) | TAAR1IDO1AGXTSLC6A3 | |
| SCHEMBL8860405 | 0.80 | AGXT (0.46) | TAAR1AGXTKDM1AMAOA | |
| SCHEMBL230856 | 0.79 | TDP1 (0.43) | TAAR1IDO1MAOBALDH1A1SMN1; SMN2 | |
| SCHEMBL20015568 | 0.78 | PLA2G1B (0.40) | TAAR1IDO1AGXTKDM1AMAOA | |
| SCHEMBL9510728 | 0.77 | TAAR1 (0.54) | TAAR1IDO1AGXTMIFMAOB | |
| SCHEMBL19007863 | 0.77 | TP53 (0.48) | L3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL27810951 | 0.77 | TAAR1 (0.46) | TAAR1IDO1MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL11853139 | 0.77 | CYP3A4 (0.41) | TAAR1IDO1AGXTMAOAMAOB | |
| Hydrochloric Acid SCHEMBL334217 | 0.77 | CYP3A4 (0.41) | TAAR1IDO1AGXTMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2705030-B1 | PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME | ZAFGEN INC (US) | 2016-07-27 | — | — | EP | disclosed |
| WO-2014071369-A1 | TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY | ZAFGEN, INC. (US) | 2014-05-08 | — | — | WO | disclosed |
| WO-2014071368-A1 | METHODS OF TREATING LIVER DISEASES | ZAFGEN, INC. (US) | 2014-05-08 | — | — | WO | disclosed |
| WO-2012154676-A9 | PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME | ZAFGEN INC. (US) | 2014-03-27 | — | — | WO | disclosed |